Moderna expects to start late-stage COVID-19 vaccine trial o
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Get authentic, real-time news that helps you fight COVID-19 better.
Install PlexusMD App for doctors. It's free.
14 July: US biotech firm Moderna said, it would enter the final stage of human trials for its Covid-19 vaccine on July 27.

The announcement came after the New England Journal of Medicine published results from the first stage of Moderna's vaccine trial, which showed the first 45 participants all developed antibodies to the virus.

The Phase 3 trial will recruit 30,000 participants in the US, with half to receive the vaccine at 100 microgram dose levels, and the other half to receive a placebo.

The Moderna vaccine belongs to a new class of vaccine that uses genetic material -- in the form of RNA -- to encode the information needed to grow the virus's spike protein inside the human body, in order to trigger an immune response.

The advantage of this technology is that it bypasses the need to manufacture viral proteins in the lab, shaving months off the standardization process and helping to ramp up mass production.

Source: https://www.bangkokpost.com/world/1951712/moderna-covid-19-vaccine-enters-final-stage-trial-this-month
Dr. T●●●●z H●●●●●●i and 8 others like this2 shares
Like
Comment
Share